XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Summary of Non-Qualified Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 1,331,591   1,370,388
Granted (in shares) 0 136,194  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised (37,411)    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures (1,386)    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1,155,912    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 61.95   $ 62.09
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 0    
Weighted Average Exercise Price, Exercises in Period (in dollars per share) 66.32    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share) 76.80    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 61.73    
Weighted Average Remaining Contractual Term, Outstanding (in years) 6 years    
Aggregate Intrinsic Value, Outstanding $ 90,797    
Weighted Average Remaining Contractual Term, Exercisable (in years) 5 years 7 months 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 79,079    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value $ 2,400    
Share-based Payment Arrangement, Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 89,550   0
Granted (in shares) 89,550 0  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 0    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $ 122.09   $ 0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 122.09    
Weighted Average Exercise Price, Exercises in Period (in dollars per share) 0    
Weighted Average Exercise Price, Forfeitures in Period (in dollars per share) 0    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 0    
Weighted Average Remaining Contractual Term, Outstanding (in years) 9 years 10 months 24 days    
Aggregate Intrinsic Value, Outstanding $ 731,176    
Weighted Average Remaining Contractual Term, Exercisable (in years) 0 years    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $ 0